Skip to content

Public FDA record

Z-0110-2018: Medtronic MiniMed(TM) Mio(TM) (MMT-921, 921T, 923, 923T, 925, 925T, 941, 941T, 943, 943T, 945, 945T, 961,

Recall record Z-0110-2018 for Medtronic Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0110-2018
Company in FDA record
Medtronic Inc.
FDA record creation date
Nov 18, 2017
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Medtronic MiniMed(TM) Infusion Sets have the potential for over-delivery of Insulin.

Source facts

Action
The firm initiated its recall on 09/11/2017 by issuing a public notice, following with letters and emails. The firm also employed the use of Facebook and Twitter as well as posting on its website. The recall notice directs the customer to visit https://checklots.medtronicdiabetes.com for information on the lot numbers. Persons with additional questions may call Medtronic at 1.888.204.7616.
Initiated
2017-09-10
Root cause
Component design/selection
Distribution
Worldwide
Recall number
Z-0110-2018
Recall status
Open, Classified
CDRH record ID
158701
FDA record created
2017-11-18
Recall event number
78125

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗